Molecular Formula | C11H10N2O2 |
Molar Mass | 202.21 |
Density | 1.22 |
Melting Point | 163-164℃ |
Solubility | DMSO: soluble15mg/mL (clear solution) |
Appearance | powder |
Color | white to beige |
Storage Condition | room temp |
In vitro study | In an in vitro kinase screening assay, MLR-1023 activated the Non-receptor-linked, Src-associated tyrosine kinase SYN. MLR-1023 increases the Vmax of yn kinase with an EC50 of 63 nM. Activation of this Lyn kinase is independent of the ATP binding site, suggesting that MLR-1023 regulates this kinase through an allosteric mechanism. |
In vivo study | MLR-1023 the blood glucose lowering effect mediated is dependent on the activity of Lyn kinase. MLR-1023 is a compound that enhances the insulin receptor and produces a rapid and long-lasting blood glucose lowering effect in animal models of diabetes. |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36 - Irritating to the eyes |
Safety Description | 26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 4.945 ml | 24.727 ml | 49.454 ml |
5 mM | 0.989 ml | 4.945 ml | 9.891 ml |
10 mM | 0.495 ml | 2.473 ml | 4.945 ml |
5 mM | 0.099 ml | 0.495 ml | 0.989 ml |